Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma - Danny Rischin; Sandro Porceddu; Fiona Day; Daniel P. Brungs; Hayden Christie; James E. Jackson; Brian N. Stein; Yungpo Bernard Su; Rahul Ladwa; Gerard Adams; Samantha E. Bowyer; Zulfiquer Otty; et al. (New England Journal of Medicine, 2025)